Investing

Viking Therapeutics : VKTX

VKTX

Stock Data

$41.14

$1.18 (2.95%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Viking Therapeutics, Inc. is a San Diego-based biopharmaceutical company focused on developing innovative treatments for metabolic and endocrine disorders. Its leading drug, VK2809, targets non-alcoholic steatohepatitis and NAFLD with a novel approach, aiming for efficacy and safety. Viking is also advancing VK5211 for hip fracture recovery, VK0612 for type 2 diabetes, VK2735 for metabolic diseases, and VK0214 for X-linked adrenoleukodystrophy, showcasing a diverse pipeline aimed at addressing significant unmet medical needs.

All Viking Therapeutics Articles

37 Articles

Joel South | 11 hours ago

3 High Growth GLP-1 Biotech Winners to Buy in July

Live Updates Tuesday Wrap-up Aug 19, 2025 at 4:12 PM EDT The Vanguard S&P 500 ETF closed at 588.15 Tuesday,…

Trey Thoelcke | Jun 23, 2026 at 7:55 AM EDT

3 Biotech Takeover Targets Wall Street Is Watching After the Apogee Deal

Live Updates Tuesday Wrap-up Aug 19, 2025 at 4:12 PM EDT The Vanguard S&P 500 ETF closed at 588.15 Tuesday,…

Trey Thoelcke | May 26, 2026 at 8:50 AM EDT

If Viking Therapeutics Is Acquired, Here’s Who Wins

Live Updates Tuesday Wrap-up Aug 19, 2025 at 4:12 PM EDT The Vanguard S&P 500 ETF closed at 588.15 Tuesday,…

Alex Sirois | May 18, 2026 at 1:55 PM EDT

Three Biotechs That Are Top Takeover Targets

Live Updates Tuesday Wrap-up Aug 19, 2025 at 4:12 PM EDT The Vanguard S&P 500 ETF closed at 588.15 Tuesday,…

Trey Thoelcke | May 14, 2026 at 9:20 AM EDT

Big Pharma’s 5 Hottest Biotech Hunting Grounds: Meet the Category Leaders

Live Updates Tuesday Wrap-up Aug 19, 2025 at 4:12 PM EDT The Vanguard S&P 500 ETF closed at 588.15 Tuesday,…

Trey Thoelcke | Apr 10, 2026 at 8:25 AM EDT

Who Benefits From Amazon Pharmacy Stocking Eli Lilly’s New Weight Loss Pill

Live Updates Tuesday Wrap-up Aug 19, 2025 at 4:12 PM EDT The Vanguard S&P 500 ETF closed at 588.15 Tuesday,…

Trey Thoelcke | Apr 1, 2026 at 7:35 AM EDT

These 5 Biotechs Could Be the Next Big GLP-1 Acquisition Target

Live Updates Tuesday Wrap-up Aug 19, 2025 at 4:12 PM EDT The Vanguard S&P 500 ETF closed at 588.15 Tuesday,…

Trey Thoelcke | Feb 16, 2026 at 9:40 AM EST

Wall Street Thinks These 4 Biotech Stocks Will Double–At Least–This Year

Live Updates Tuesday Wrap-up Aug 19, 2025 at 4:12 PM EDT The Vanguard S&P 500 ETF closed at 588.15 Tuesday,…

Ian Cooper | Dec 23, 2025 at 8:58 AM EST

Premarket Movers: Albemarle Gaining Momentum on Lithium Boom

Live Updates Tuesday Wrap-up Aug 19, 2025 at 4:12 PM EDT The Vanguard S&P 500 ETF closed at 588.15 Tuesday,…

Rich Duprey | Nov 3, 2025 at 10:13 AM EST

Viking Therapeutics Could Be Pharma’s Next Big Buyout Target

Live Updates Tuesday Wrap-up Aug 19, 2025 at 4:12 PM EDT The Vanguard S&P 500 ETF closed at 588.15 Tuesday,…

Ian Cooper | Oct 31, 2025 at 10:18 AM EDT

3 Explosive Stocks With High Short Interest

Live Updates Tuesday Wrap-up Aug 19, 2025 at 4:12 PM EDT The Vanguard S&P 500 ETF closed at 588.15 Tuesday,…

Ian Cooper | Oct 30, 2025 at 9:40 AM EDT

3 Explosive Stocks With High Short Interest

Live Updates Tuesday Wrap-up Aug 19, 2025 at 4:12 PM EDT The Vanguard S&P 500 ETF closed at 588.15 Tuesday,…

Rich Duprey | Aug 27, 2025 at 8:23 AM EDT

Eli Lilly’s Obesity Pill Breakthrough Shakes Up $150 Billion Weight-Loss Race

Live Updates Tuesday Wrap-up Aug 19, 2025 at 4:12 PM EDT The Vanguard S&P 500 ETF closed at 588.15 Tuesday,…

Rich Duprey | Aug 22, 2025 at 12:13 PM EDT

Novo Nordisk Roars Back: 6 Catalysts Driving the Pharma’s Path to Dominance

Live Updates Tuesday Wrap-up Aug 19, 2025 at 4:12 PM EDT The Vanguard S&P 500 ETF closed at 588.15 Tuesday,…

Joel South | Aug 19, 2025 at 9:08 AM EDT

Stock Market Live August 19: S&P 500 (VOO) Rally Still on Hold Pending Fed Talk

Live Updates Tuesday Wrap-up Aug 19, 2025 at 4:12 PM EDT The Vanguard S&P 500 ETF closed at 588.15 Tuesday,…